All 1 tracked stories fall under one category: market-trends. Solventum is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 5 average consequence score is below the beat benchmark of 5.8 in the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about 3M
All 1 tracked stories fall under one category: market-trends. Solventum is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 5 average consequence score is below the beat benchmark of 5.8 in the same window. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline. 3M appears in 1 tracked Healthcare story from March 24, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering 3M. Shared-story counts are live from our verified record — not editorial picks.
Solventum (SOLV) shares experienced a notable decline on Tuesday, reflecting investor concerns over the company's ability to maintain margins following its high-profile spin-off from 3M. The downward movement comes amid broader market volatility affecting growth-oriented healthcare technology and medical device firms.
3M is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.